发明人刘建华,孙丽萍,郑宇鹏. "Method for the Synthesis of 3-(3-Chlorophenyl)-5-(piperidin-2-yl)-1,2,4-oxadiazole" [P]. 中国发明专利, 专利号 CN 113734712 A, 授权公告日 2025-06-17.
发明人何建平,刘建华,李文辉. "A Process for Preparing High-Purity 3-(3-Chlorophenyl)-5-(piperidin-2-yl)-1,2,4-oxadiazole" [P]. 中国发明专利, 专利号 CN 117018230 A, 授权公告日 2023-03-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 2136, (8), 4449-4469.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2014, 1633, (6), 5475-5497.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-Chlorophenyl)-5-(piperidin-2-yl)-1,2,4-oxadiazole Using HRMS and NMR". Talanta, 2017, 1045, (11), 1885-1904.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2012, 945, (9), 777-799.